H2AX and glioblastoma: The western blotting results demonstrated that both sequential and concurrent application of TMZ and ABX treatment significantly increased the expression of γ-H2AX protein in GBM cells compared to TMZ mono-treatment and control group (Fig. 3a and Figure S6).